September 13, 2006, London, ON - What if your
doctor could use DNA analysis to ensure that they
prescribe the right medications, in the right
amounts at the right time for each person they
see? Imagine fewer side-effects, fewer adverse
drug reactions or toxicity problems and customized
drug treatment options that are safe and effective
for each and every person and you will begin to
understand the benefits of Dr.
Richard Kim`s research in personalized medicine,
also called "pharmacogenomics."
Dr. Kim, a Canadian physician-scientist and
leading researcher in the field of personalized
medicine, has decided to relocate his lab and his
research team from Vanderbilt University School
of Medicine, in Nashville, Tennessee to London,
Ontario.
With appointments at London Health Sciences
Centre, Lawson Health Research Institute and
Schulich School of Medicine and Dentistry at The
University of Western Ontario, Dr. Kim will be
Clinical Pharmacologist, Chair/Chief Division of
Clinical Pharmacology, and Professor of Medicine.
He will also be the inaugural Medical Director
of the new Clinical Investigation Unit (CIU) at the
Legacy Research Building at University Hospital,
which is one of the first centres of its kind in
Canada for bench to bedside research and clinical
trials. "What makes this so exciting is that there are
a number of truly outstanding scientists, both at
the basic and clinical levels in London, who can
make things happen. By pooling equipment and
people in one core facility we will optimize
resources, ensuring patients receive the latest and
greatest
care," said Dr. Kim.
Dr. Kim and his team were formally welcomed
to London at a press conference this morning at
University Hospital, hosted by London Health
Sciences Centre, Lawson and Western`s Schulich
School of Medicine & Dentistry.
Julia Capaldi
Lawson Health Research Institute
Tel: (519) 646-6100 ext. 61098
Fax: (519) 646-6110
Helping people live healthier lives through
advanced science in a patient care setting.